kinthera bpc 157 BPC-157 – Mark Hyman, MD BPC-157 — Vynta
Description
Vitamin K and Osteoporosis
The research base for BPC-157 is unusually broad
Therefore, again, there is no convincing certainty that BPC 157 is harmless because, as just mentioned, some of the probable metabolites can be responsible for various adverse effects or trigger a cascade of other events leading directly or indirectly to possible side effects
Cycle structure: 1 to 3 months on therapy, followed by 2 to 3 months off, with a 5-days-on, 2-days-off weekly schedule
97 B12 requirements are increased during pregnancy
